期刊文献+

Lactic Acid Inhibits NF-kB Activation by Lipopolysaccharide in Rat Intestinal Mucosa Microvascular Endothelial Cells 被引量:7

Lactic Acid Inhibits NF-kB Activation by Lipopolysaccharide in Rat Intestinal Mucosa Microvascular Endothelial Cells
下载PDF
导出
摘要 To investigate whether lactic acid could inhibit the LPS-activation of NF-κB p65 in rat intestinal mucosa microvascular endothelial cells (RIMMVECs), RIMMVECs, cultured in vitro, were pretreated with different concentrations of lactic acid and then exposed to lipopolysaccharide (LPS). Cells and cell culture media were then collected at different time intervals. Production of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) was examined at the protein level by enzyme-linked immunosorbent assay. The influence of lactic acid on the LPS-activation of NF-κB was examined at mRNA and protein levels by real-time quantitative PCR and Western blot analysis, respectively. TNF-a and IL-6 protein levels were significantly decreased after pretreatment with lactic acid compared with cells exposed to LPS only. After pretreatment with 7.5, 5.0, and 2.5 μL mL-1 lactic acid, NF-κB mRNA levels were increased by 1.51-, 2.62- and 3.00-fold, respectively, compared with levels in control cells without LPS treatment. Western blot analysis indicated that the level of NF-κB p65 in the lactic acid-pretreated group was significantly lower than that in the group treated with LPS only (positive control) and was unchanged compared with the group without LPS treatment (blank control). These results suggest that lactic acid may inhibit LPS-activation of NF-κB, leading to the down-regulation of TNF-a and IL-6. To investigate whether lactic acid could inhibit the LPS-activation of NF-κB p65 in rat intestinal mucosa microvascular endothelial cells (RIMMVECs), RIMMVECs, cultured in vitro, were pretreated with different concentrations of lactic acid and then exposed to lipopolysaccharide (LPS). Cells and cell culture media were then collected at different time intervals. Production of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) was examined at the protein level by enzyme-linked immunosorbent assay. The influence of lactic acid on the LPS-activation of NF-κB was examined at mRNA and protein levels by real-time quantitative PCR and Western blot analysis, respectively. TNF-a and IL-6 protein levels were significantly decreased after pretreatment with lactic acid compared with cells exposed to LPS only. After pretreatment with 7.5, 5.0, and 2.5 μL mL-1 lactic acid, NF-κB mRNA levels were increased by 1.51-, 2.62- and 3.00-fold, respectively, compared with levels in control cells without LPS treatment. Western blot analysis indicated that the level of NF-κB p65 in the lactic acid-pretreated group was significantly lower than that in the group treated with LPS only (positive control) and was unchanged compared with the group without LPS treatment (blank control). These results suggest that lactic acid may inhibit LPS-activation of NF-κB, leading to the down-regulation of TNF-a and IL-6.
出处 《Agricultural Sciences in China》 CAS CSCD 2011年第6期954-959,共6页 中国农业科学(英文版)
基金 supported by the Natural Science Foundation of Beijing, China (6072007) the Project for the Establishment and Development of Swine Disease Clinical Diagnosis, China (KM200910020002)
关键词 lactic acid RMMIVECs LPS NF-κB lactic acid, RMMIVECs, LPS, NF-κB
  • 相关文献

参考文献22

  • 1Calzado M A, Bacher S, Schmitz M L. 2007. NF-κB inhibitors for the treatment of inflammatory diseases and cancer. Current Medicinal Chemistry, 14, 367-376.
  • 2Camandola S, Mattson M P. 2007. NF-κB as a therapeutic target in neurodegenemtive diseases. Expert Opinion on Therapeutic Targets, 11, 123-132.
  • 3Choi J, Enis D R, Koh K P, Shiao S L, Pober J S. 2004. T lymphocyte-endothelial cell interactions. Annual Review of Immunology, 22, 683-689.
  • 4Collins T, Read M A, Neish A S, Whitley M Z, Thanos D, Maniatis T. 1995. Transcriptional reeulation of endothelial cell adhesion molecules: NF-κB and cvtokine-inducible enhancers. FASEB Journal, 9, 899-909.
  • 5Cordle S R, Donald R, Read M A, Hawiger J. 1993. Lipopoly-saccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. Journal of Biological Chemistry, 268, 11803- 11810.
  • 6Feldmann M, Maini R N. 2001. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned. Annual Review of Immunology, 19, 163-196.
  • 7Hindryckx P, de Vos M, Jacques P, Ferdinande L, Peeters H, Olievier K, Bogaert S, Brinkman B, Vandenabeele P, Elewaut D, et al. 2010. Hydroxylase inhibition abrogates TNF-α- induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. The Journal of Immunology, 185, 6306-6316.
  • 8Kaileh M, Sen R. 2010. Role of NF-κB in the anti-inflammatory effects of Tocotrienols. Journal of the American College of Nutrition, 29, 334s-339s.
  • 9Karin M. 2006. Nuclear factor-κB in cancer development andprogression. Nature, 441, 431-436.
  • 10Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, Csipo I, Sipka S, Seres I, Paragh G, etal. 2008. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. The Journal of Rheumatology, 35, 398-406.

同被引文献53

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部